3 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Antiviral Defense in the Vector Mosquito Aedes aegypti: induction and suppression of RNA silencing pathways (ViVARNAsilencing)
Date du début: 1 août 2014, Date de fin: 31 juil. 2019,
BACKGROUND: Mosquitoes and other blood-feeding arthropods transmit important human and animal viruses (arthropod-borne viruses, arboviruses). With the increasing global threat of arboviruses, it is essential to understand the virus-vector interactions that determine virus transmission. The mosquito antiviral immune response is a key determinant of virus replication and transmission. We recently sh ...
Voir le projet
1
Participant partenaire
TERMINÉ
QUantitative Imaging in Cancer: CONnecting CEllular Processes with Therapy (QUIC-CONCEPT)
Date du début: 1 sept. 2011, Date de fin: 31 déc. 2017,
The QuIC-ConCePT consortium has 2 objectives: 1.(90% of resource, WP2-5) to qualify 3 specific imaging biomarkers (IBs) of tumour cell proliferation, apoptosis, and necrosis, to allow drug developers to demonstrate reliably modulation of these pathologic processes in tumours in patients in realistic trials. Our vision for January 2016 is that drug developers can incorporate these IBs for decision- ...
Voir le projet
26
Participants partenaires
TERMINÉ
DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE (DRIVE-AB)
Date du début: 1 oct. 2014, Date de fin: 30 sept. 2017,
Antimicrobial resistance (AMR) is widespread. Its global human and economic burden is tremendous and increasing annually. Yet today only a few pharmaceutical companies retain active antibacterial drug discovery programmes. While the elaboration of antibiotics with novel mechanisms of action is scientifically complex, the chief challenge is diminishing incentives. Pre-market regulatory requirements ...
Voir le projet